J Clin Neurol.  2014 Jan;10(1):32-36.

CAG-Expansion Haplotype Analysis in a Population with a Low Prevalence of Huntington's Disease

• Pulkes T
• Papsing C
• Wattanapokayakit S
• Mahasirimongkol S

Abstract

BACKGROUND AND PURPOSE
The prevalence of Huntington's disease (HD) among East Asians is less than one-tenth of that among Caucasians. Such a low prevalence may be attributable to a lack of carriers of specific predisposing haplogroups associated with the high instability of the Huntingtin gene (HTT). The aim of this study was to evaluate the association between specific HTT haplogroups and the occurrence of HD in a Thai population.
METHODS
CAG-repeat sizes and HTT haplotypes were analyzed in 18 Thai HD patients and 215 control subjects. Twenty-two tagging single-nucleotide polymorphisms (tSNPs) were genotyped.
RESULTS
Only 18 patients from 15 unrelated families were identified over the last 17 years. Pathological CAG-repeat alleles ranged from 39 to 48 repeats (43.5+/-3.0, mean+/-SD), and normal alleles ranged from 9 to 24 repeats (16.49+/-1.74). Only two of the chromosomes studied comprised intermediate alleles. Unlike the Caucasian data, all but 1 of the 22 tSNPs were not associated with the occurrence of HD. The predisposing haplogroups for Caucasian HD (haplogroups A1 and A2) are very rare in Thai patients (<4%). Both HD and normal chromosomes are commonly haplogroups A5 and C, in contrast to the case for Chinese and Japanese patients, in whom only haplogroup C was common in HD chromosomes. The frequency of CAG-repeat sizes of haplogroup A5 and C were also similarly distributed.
CONCLUSIONS
HD chromosomes of Thai patients may arise randomly from each haplogroup, with a similar mutation rate. This rate is much lower than the CAG expansions from Caucasian HD haplogroups. These data suggest that the different mechanisms underlie CAG expansion in Thai and Caucasian patients.

Keyword

Huntington's disease; CAG repeat; haplogroup; prevalence; intermediate allele

MeSH Terms

Alleles
Asian Continental Ancestry Group
Haplotypes*
Humans
Huntington Disease*
Mutation Rate
Prevalence*

Figure

• 

  Fig. 1 CAG-repeat sizes of haplogroups A5 and C showed similar distributions (p=0.2755).

Reference

1. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993; 72:971–983.

2. Conneally PM. Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984; 36:506–526.

3. Palo J, Somer H, Ikonen E, Karila L, Peltonen L. Low prevalence of Huntington's disease in Finland. Lancet. 1987; 2:805–806.

4. Spinney L. Uncovering the true prevalence of Huntington's disease. Lancet Neurol. 2010; 9:760–761.

5. Nakashima K, Watanabe Y, Kusumi M, Nanba E, Maeoka Y, Nakagawa M, et al. Epidemiological and genetic studies of Huntington's disease in the San-in area of Japan. Neuroepidemiology. 1996; 15:126–131.

6. Hayden MR, MacGregor JM, Beighton PH. The prevalence of Huntington's chorea in South Africa. S Afr Med J. 1980; 58:193–196.

7. Chang CM, Yu YL, Fong KY, Wong MT, Chan YW, Ng TH, et al. Huntington's disease in Hong Kong Chinese: epidemiology and clinical picture. Clin Exp Neurol. 1994; 31:43–51.

8. Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H, et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet. 2009; 84:351–366.

9. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001; 68:978–989.

10. Squitieri F, Andrew SE, Goldberg YP, Kremer B, Spence N, Zeisler J, et al. DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet. 1994; 3:2103–2114.

11. Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994; 330:1401–1406.

12. Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet. 1993; 4:387–392.

13. Soong BW, Wang JT. A comparison of the Huntington's disease associated trinucleotide repeat between Chinese and white populations. J Med Genet. 1995; 32:404–405.

14. Sequeiros J, Ramos EM, Cerqueira J, Costa MC, Sousa A, Pinto-Basto J, et al. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet. 2010; 78:381–387.

15. Maat-Kievit A, Losekoot M, Van Den Boer-Van Den Berg H, Van Ommen GJ, Niermeijer M, Breuning M, et al. New problems in testing for Huntington's disease: the issue of intermediate and reduced penetrance alleles. J Med Genet. 2001; 38:E12.

16. Chong SS, Almqvist E, Telenius H, LaTray L, Nichol K, Bourdelat-Parks B, et al. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. Hum Mol Genet. 1997; 6:301–309.

17. Falush D, Almqvist EW, Brinkmann RR, Iwasa Y, Hayden MR. Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. Am J Hum Genet. 2001; 68:373–385.

18. Ramos-Arroyo MA, Moreno S, Valiente A. Incidence and mutation rates of Huntington's disease in Spain: experience of 9 years of direct genetic testing. J Neurol Neurosurg Psychiatry. 2005; 76:337–342.

19. Warby SC, Visscher H, Collins JA, Doty CN, Carter C, Butland SL, et al. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet. 2011; 19:561–566.